According to Glaukos's latest financial reports the company's current EPS (TTM) is -$2.69. In 2022 the company made an earnings per share (EPS) of -$2.09 a decrease over its 2021 EPS that were of -$1.08.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.69 | 28.71% |
2022 | -$2.09 | 93.52% |
2021 | -$1.08 | -60.44% |
2020 | -$2.73 | -902.94% |
2019 | $0.34 | -191.89% |
2018 | -$0.37 | 5.3322619588067E+18% |
2017 | -$0.0000000000 | -100% |
2016 | $0.13 | -101.2% |
2015 | -$11.12 | 2182.57% |
2014 | -$0.49 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ICU Medical
ICUI | -$2.02 | -24.91% | ๐บ๐ธ USA |
AtriCure ATRC | -$0.54 | -79.93% | ๐บ๐ธ USA |
Integra LifeSciences IART | $1.22 | -145.35% | ๐บ๐ธ USA |